SHELTON, Conn.--(BUSINESS WIRE)-- #Compliance--While biosimilars offer up to 90% savings over their specialty drug counterparts, uptake in the U.S. has been slow. PBIRx, a national leader in pharmacy benefit consulting and auditing, hosted an insightful webinar today, Biosimilars: The New Savings Frontier, providing actionable insights into the biosimilar market landscape, regulatory influences, and PBM strategies for plan sponsors. The webinar featured a top panel of PBIRx pharmacists including